sb 202190 has been researched along with Edema in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khoshneviszadeh, M | 1 |
| Ghahremani, MH | 1 |
| Foroumadi, A | 1 |
| Miri, R | 1 |
| Firuzi, O | 1 |
| Madadkar-Sobhani, A | 1 |
| Edraki, N | 1 |
| Parsa, M | 1 |
| Shafiee, A | 1 |
1 other study available for sb 202190 and Edema
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel anti-cytokine 1,2,4-triazine derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Carrageenan; Cell Survival; Cells, | 2013 |